Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04176705 · ClinicalTrials.gov registry record · NA
Fractional Ablative Laser Treatment for Skin Grafts
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04176705: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT04176705 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04176705, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Doctors and patients refer to all areas of skin changes from burn injury as burn scars. However, different areas of scars from burns can be treated differently. The burn scars that come from skin grafting surgery might be improved with laser treatment. The purpose of this study is to see if treating burn skin graft scars with a laser could make it better. Fractional Ablative Laser has been approved by the US Food and Drug Administration (FDA), but it has not been approved for use in the early stages of scar maturation and is considered investigational for this study.
Primary Outcome
Contracture of Scar Surface Area 90 days post grafting: The surface area of the skin graft cm\^2 at about 90 days after skin grafting will be compared to the size of the original skin graft at about one week after surgery.
Interventions
- DRUG Lidocaine Cream
- DRUG Triamcinolone Acetonide Cream
- DEVICE Fractional Ablative Laser
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2023-09-29 |
| Phase | NA |
What the finished NCT04176705 record still lists
NCT04176705 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Lidocaine Cream is the first listed.
NCT04176705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04176705 about?
NCT04176705 is a clinical study titled "Fractional Ablative Laser Treatment for Skin Grafts". Doctors and patients refer to all areas of skin changes from burn injury as burn scars. However, different areas of scars from burns can be treated differently. The burn scars that come from skin grafting surgery might be improved with laser treatment. The purpose of this study is to see if treating...
What is the current status of trial NCT04176705?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2020-12-14. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT04176705?
The interventions under investigation include: Lidocaine Cream (DRUG), Triamcinolone Acetonide Cream (DRUG), Fractional Ablative Laser (DEVICE).
Who is sponsoring clinical trial NCT04176705?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04176705's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI